CD86 and stroke disorder: Additionally, quantitative analysis showed no marked difference in the mRNA expressions of other chemokines and inflammatory genes, such as CD80, IL34, CD86, CXCL10, CCL2, CCL4, and CCL5, between the vehicle-treated and ki20227-treated stroke mice on day 3 (Figures 3B,C).